NCT01812317

Brief Summary

Fire-fighters are at increased risk of death from heart attacks when compared to other emergency service professionals whose jobs involve similar components such as emergency call-outs and shift work. The unique risk to fire-fighters is likely to reflect a combination of factors including extreme physical exertion, mental stress, heat and pollutant exposure. In the largest analysis of cause of death amongst on-duty fire-fighters, fire-fighter deaths were classified according to the duty performed during the onset of symptoms or immediately prior to any sudden death. The majority of deaths due to a cardiovascular cause (i.e. heart attack) occurred during fire-suppression whilst this activity represented a relatively small amount of a fire-fighters professional time. Fire simulation training centers offer a unique opportunity to assess the heart, blood and blood vessel response to fire suppression in a controlled environment. In this study the investigators will assess healthy career fire-fighters on two occasions: following a fire-suppression training exercise in a purpose built real-fire training center, and following a sedentary period as a control. The investigators will take blood samples to measure platelet activity (platelets are the particles in blood that help blood clot) and will examine how blood clots outside of the body. The investigators will then perform studies placing small needles in the arm to assess blood vessel function following fire suppression. By undertaking this comprehensive assessment of blood, blood vessel and heart function we hope to understand the mechanisms whereby the risk of a heart attack is influenced by fire suppression. The investigators hypothesize that following the fire-suppression exercise firefighters blood will clot more readily and their blood vessels will not relax properly which are two of the main processes in the development of a heart attack.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
19

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2012

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2012

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

March 4, 2013

Completed
14 days until next milestone

First Posted

Study publicly available on registry

March 18, 2013

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2016

Completed
Last Updated

June 21, 2021

Status Verified

June 1, 2021

Enrollment Period

4.4 years

First QC Date

March 4, 2013

Last Update Submit

June 17, 2021

Conditions

Keywords

firefightersfire-simulation trainingmyocardial infarctionendothelial functionthrombosis

Outcome Measures

Primary Outcomes (1)

  • Forearm blood flow measured by venous occlusion plethysmography in response to infused vasodilators

    3-6 hours post exposure

Secondary Outcomes (2)

  • Ex-vivo thrombus formation using the Badimon chamber

    2 hours post exposure

  • Plasma t-PA and PAI concentrations following infusion of bradykinin

    During forearm study, 3-6 hours post exposure

Study Arms (2)

Real-fire training exercise

ACTIVE COMPARATOR

Subjects will undergo a 20 minute standardised training exercise in a fire simulation facility.

Procedure: Forearm Vascular StudyProcedure: Badimon Chamber Study

Sedentary training session

SHAM COMPARATOR

Subjects will undergo a training exercise where they will remain sedentary for 20 mins in an ambient temperature.

Procedure: Forearm Vascular StudyProcedure: Badimon Chamber Study

Interventions

Forearm venous occlusion plethysmography to measure forearm blood flow during intra-arterial infusion of the vasodilators Verapamil (10-100 µg/min), bradykinin (100-1000 pmol/min), sodium nitroprusside (2-8 µg/min) and Acetylcholine (5-20 µg/min).

Also known as: BK, SNP, ACh, VP
Real-fire training exerciseSedentary training session

Ex-vivo assessment of thrombus formation using the Badimon Chamber

Real-fire training exerciseSedentary training session

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Non-smoking healthy firefighters

You may not qualify if:

  • Current smoker
  • History of lung or ischaemic heart disease
  • Malignant arrhythmia
  • Systolic blood pressure \>190mmHg or \<100mmHg
  • Renal or hepatic dysfunction
  • Previous history of blood dyscrasia
  • Unable to tolerate the supine position
  • Blood donation within the last 3 months
  • Recent respiratory tract infection within the past 4 weeks
  • Routine medication including aspirin and NSAIDs

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Royal Infirmary of Edinburgh Clinical Research Facility

Edinburgh, EH16 4SA, United Kingdom

Location

Related Publications (1)

  • Hunter AL, Shah AS, Langrish JP, Raftis JB, Lucking AJ, Brittan M, Venkatasubramanian S, Stables CL, Stelzle D, Marshall J, Graveling R, Flapan AD, Newby DE, Mills NL. Fire Simulation and Cardiovascular Health in Firefighters. Circulation. 2017 Apr 4;135(14):1284-1295. doi: 10.1161/CIRCULATIONAHA.116.025711.

MeSH Terms

Conditions

ThrombosisMyocardial Infarction

Condition Hierarchy (Ancestors)

Embolism and ThrombosisVascular DiseasesCardiovascular DiseasesMyocardial IschemiaHeart DiseasesInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosis

Study Officials

  • David E Newby, MD PhD

    University of Edinburgh

    STUDY CHAIR
  • Nicholas L Mills, MBChB PhD

    University of Edinburgh

    STUDY DIRECTOR
  • Amanda L Hunter, MBChB

    University of Edinburgh

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 4, 2013

First Posted

March 18, 2013

Study Start

April 1, 2012

Primary Completion

September 1, 2016

Study Completion

September 1, 2016

Last Updated

June 21, 2021

Record last verified: 2021-06

Locations